Bodei, Serena <br/><br/>
Should we be cautious on the use of commercially available antibodies to dopamine receptors?  [electronic resource] 

 -  Naunyn-Schmiedeberg's archives of pharmacology  Apr 2009 
 - 413-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Validation Study 
<br/><br/><label>ISSN: </label>1432-1912 
<br/><br/><label>Standard No.: </label>10.1007/s00210-008-0384-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies--immunology<br/>Antibody Specificity--immunology<br/>Blotting, Western<br/>Cell Line<br/>Humans<br/>Receptors, Dopamine--analysis<br/>Receptors, Dopamine D1--analysis<br/>Receptors, Dopamine D2--analysis<br/>Receptors, Dopamine D3--analysis<br/>Receptors, Dopamine D4--analysis<br/>Receptors, Dopamine D5--analysis<br/>Transfection